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Introduction: Late initiation of  anti-retroviral therapy (ART) is associated with low immunologic response, increase morbidity, 
mortality and hospitalization. Therefore, this study aimed to assess the prevalence and factors associated with late ART initiation 
among adult HIV patients in NorthWest Ethiopia.
Methods: Retrospective cross-sectional study was conducted among 412 HIV patients who started ART between January/2009 
and December/2014. Simple random sampling technique was used to select patient records. Data were collected by using pre-
tested and structured extraction tool. Binary logistic regression model was fitted to identify factors associated with late ART 
initiation.
Result: A total of  410 participants were included for analysis after excluding 2 participants with incomplete data. The prev-
alence of  late ART initiation was 67.3%. Age between 35-44 years(AOR=3.85; 95%CI:1.68-8.82), duration between testing 
and enrollment to care<1year (AOR=2.19;95%CI:1.30-3.69), secondary education (AOR=2.59; 95%CI 1.36-4.94), teritary ed-
ucation(AOR=3.28; 95%CI 1.25-8.64), being unmarried(AOR=1.88; 95%CI 1.13-3.03), bedridden and ambulatory patients 
(AOR=4.68 95%CI:1.49-14.68), other medication use before ART initiation(AOR=2.18; 95%CI 1.07-4.44), starting ART be-
tween 2009-2010 (AOR=5.94; 95%CI 2.74-12.87) and  2011-2012(AOR=2.80; 95%CI 1.31-5.96) were significantly associated 
with late ART initation at p-value <0.05.
Conclusion: The prevalence of  late ART initiation was high. Strengthening the mechanisms of  early HIV testing and linkage 
to care are recommended to initiate treatment earlier.
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Introduction
Antiretroviral therapy (ART) has significantly improve 
the quality of  life of  the patient by reducing morbidi-
ty and mortality1,2. Early diagnosis of  HIV and initiation 
of  ART in low resource and high HIV prevalent coun-
tries minimize the cost of  hospitalization and maximize 
the benefit of  ART3,4.  However, the high magnitude of  
late ART initiation causes low immunologic response, in-
creased HIV related morbidity, mortality and hospitaliza-
tion of  the patient1,5,6.
There were frequent changes in ART guideline to ex-
pand ART eligible patients in resource limited settings, 
including Sub Saharan Africa. Despite this change most 
HIV patients still starting treatment at a very low CD4 
cell count and advanced disease5,7,8. The median CD4 
cell count at initiation of  ART was 150 cell/μl in Asia9, 
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122 cells/μl in sub-Saharan region5,9, and 132 cell/μl in 
Uganda10.  It is still a major challenge for the success of  
treatment. The prevalence of  late ART initiation in Latin 
America and Caribbean was found to be 76 %11, Cana-
da 48%2, Australia 20 %6, Nigeria 63 %12, Lesotho 45.7 
%1, Mozambique 38 %13, Uganda 37.7%10, Cameron 35.5 
%14,  and Ethiopia 31.2%15.
In Ethiopia, the median CD4 count at enrollment to care 
is increased from 158 cell/μl to 208 cell/ μl but the me-
dian CD4 cell count at ART initiation remained stable 
and  pre-ART attrition contributed a lot16. In response to 
this, since 2010, the Ethiopian government updated ART 
initiation criteria three times. In 2010 the initiation criteria 
were CD4<350 cell/µl and/WHO Stage III/IV, whereas 
in 2014 the initiation criteria was CD4 count<500 cell/
µl17. Since 2015, to scale up the ART program, Ethio-
pia has implemented the HIV/AIDS prevention care and 
treatment strategic plan in an investment case approach 
with United Nations Programme on HIV/AIDS (UN-
AIDS) 90-90-90 strategies. One of  the  regional as well 
as national strategies for achievement is the test and treat 
initiatives18.
Late initiation causes a serious public health problems 
which results inadequate immune response, premature 
mortality of  patients and increased HIV transmission19. 
Additionally, high levels of  virological failure are com-
mon among those individual who start ART at low CD4 
count20.  To prevent the problem it is important to iden-
tify factors contributing for late initiation. Studies in 
sub-Saharan Africa reported many contributing factors 
for late ART initiation8, which  includes;  late HIV di-
agnosis7,21, late enrollment to care,  years of  ART initi-
ation9,12,13, low CD4 count at enrollment to care, female 
sex , younger and older age2,14, unmarried  and low level 
of  education10,14. Therefore, the aim of  this study was to 
determine the prevalence and associated factors of  late 
ART initiation among adult HIV infected patients who 
started highly active Anti retro viral therapy (HAART) at 
University of  Gondar Hospital from January 2009 to De-
cember 2014. The result of  this study will help to evaluate 
the HIV treatment program over time and provide evi-
dence for future intervention in prevention of  late ART 
initiation.  
Methods
Study design and period
An institution based retrospective cross-sectional study 
was conducted at the university of  Gondar hospital ART 
clinic from January 2009 to December 2014.Gondar is 
about 750 km far from the NorthWest of  Addis Ababa, 
which is the capital city of  Ethiopia. Gondar hospital is 
a teaching Hospital, which serves more than five million 
people. The hospital started ART service in 2005. More 
than 7500 adults and 700 pediatric patients were enrolled 
in the HIV care from the time in which the hospital start-
ed HIV care. Currently more than 4900 adults are actively 
receiving care in this hospital. For this particular study 
participants were adult HIV patients who were started 
HAART at University of  Gondar Hospital from January 
2009 to December 2014.
Inclusion criteria
All patients aged 15 and above who were started HAART 
at university of  Gondar Hospital, from January 2009 to 
December 2014. Within this period, a total of  2,520 pa-
tients started ART and fulfilled the inclusion criteria. Re-
cords with no CD4 measurement and/WHO staging one 
months before or after ART initiation were excluded.
Sample size and sampling technique
The sample size was determined by using single popu-
lation proportion formula through EPI INFO StatCalc 
program with the assumption of  95% level of  confi-
dence, 5% of  marginal error, and by taking 50% preva-
lence for late ART initiation. With these assumptions, the 
calculated sample size was 384. Considering 10% expect-
ed incomplete record the final sample size was 412. The 
patients’ chart number was taken from the electronic data 
base of  the Hospital and 412(out of  2520) charts were 
selected through a computer generated random number.
Operational definition
Late ART initiation was defined as having a CD4 count 
of  below or through 200 cell/µl and/AIDS defining ill-
ness17. CD4 count or WHO stage at ART initiation in-
cluded those measurement taken with in one months be-
fore and after initiation of  ART. Those participants who 
were taking any of  the three commonly used psychoac-
tive substances: alcohol, cigarette and/or Khat in the past 
30 days/span> were considered as substance user22.
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Data collection tools and procedures
Data were collected by using data extraction tool. The 
tool was developed from different literature2,13, patient’s 
national standard follow up chart which was adapted from 
WHO guidelines23 and patients medical records. The data 
were collected by four nurses who took an ART training. 
A data clerk supported data collectors in identifying the 
charts. Charts were retrieved using the patient’s registra-
tion number which was found in the electronic database 
established by I-TECH Ethiopia.
Data quality control
To maintain quality of  data the recruited data collectors 
were trained for ART training. Prior to data collection, 
One day training was given to data collectors about the 
aim of  the study and how to retrieve data. Pretest was 
done on 20 patients’ records to check the consistency and 
completeness of  the data item. The data collection pro-
cess was monitored by the investigator throughout the 
data collection period. Completed extraction tool were 
checked regularly for completeness of  information.
Data processing and analysis
Before the analysis, the collected data was checked for 
its completeness before and after entry. For those hav-
ing incomplete or missing data, the collected data from 
the extraction tool and the original patient records were 
reviewed again by using the assigned code. Data were 
checked, coded and entered to EPI INFO version 7 then 
it was exported to SPSS version 20 for analysis. Both 
descriptive and analytical statistical procedures were uti-
lized. Descriptive statistics like percentage, mean, median 
standard deviation and Interquartile range (IQR) were 
used for the presentation of  socio-demographic data and 
prevalence of  late ART initiation.  Tables were also used 
for data presentation. Binary logistic regression was used 
to identify factors associated with late ART initiation 
among adult HIV patients. Multivariable logistic regres-
sion model was fitted to control the possible effect of  
confounders and finally the variables which had indepen-
dent association with late ART initiation were identified 
on the basis of  OR (95% CI) and p-value (less than 0.05). 
The variables were entered in the multivariable model 
using the Backward Stepwise regression method. Model 
fitness was checked using Hosmer and Lemeshow good-
ness of  fit test (P= 0.51).
Ethical considerations
The study was approved by College of  Medicine and 
Health Sciences Research and Ethical committee and In-
stitutional Review Board of  University of  Gondar. A per-
mission and supportive letter was obtained from clinical 
directors of  the hospital. To retrieve the data from the 
patients’ record permission was obtained from ART clin-
ic head. To ensure confidentiality, personal identifiers like 
name were not registered in the extraction tool.
Results
Baseline socio-demographic, clinical and immuno-
logical status of  the respondents 
A total of  412 records were reviewed, of  which two were 
excluded because of  data incompleteness. Finally, 410 
participants were included in the analysis (Table 1).  More 
than half  265 (64.6%) of  respondent were females. The 
mean (SD) age of  the patients at ART initiation was 33.3 
+ 8.7 years. The majority of  respondents, 337 (82.2%) 
were urban residents. Regarding the level of  education; 
123 (30.00%) of  the respondents had completed their 
secondary education. One hundred seventy two (42.0%) 
and 150 (36.60%) of  the respondent starts HAART at 
WHO stage III and between CD4 count of  100 and 199 
cell/ µl respectively. A total of  372 (90.7%) patients had 
disclosed their HIV status to either their family or other 
relatives. Three hundred fifty nine (87.6%) of  the respon-
dents did not use any type substance.
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Table 1: Socio demographic and clinical characteristics of the respondents, University of Gondar  
hospital, Northwest Ethiopia, January 2009-December 2014 (n=410) 
Characteristics Frequency  Percentage (%) 
Age in year 15-24 51 12.4 
  25-34 181 44.1 
  35-44 126 30.7 
  > 45 52 12.7 
Sex Male 145 35.4 
  female 265 64.6 
Marital Status single 73 17.8 
  married 186 45.5 
  divorce 96 23.44 
  Widowed 31 7.6 
  Separated 24 5.9 
Religion Orthodox 363 88.5 
  Muslim 39 9.5 
  Protestant 6 1.5 
  Jewish and  Catholic 2 0.4 
Level of Educational Not educated 127 31 
  Primary 102 24.9 
  Secondary 123 30 
  Tertiary 58 14.1 
Occupation Unemployed 326 79.52 
  Employed 84 20.48 
Residence Urban 337 82.2 
  Rural 73 17.8 
Disclosure status Disclosed 372 90.7 
  Not Disclosed 38 9.3 
Substance use No 359 87.6 
  Yes 51 12.4 
Functional status Working 361 88 
  Ambulatory 29 7.1 
  Bedridden 20 4.9 
CD4 count       
  <100 cell/mm3 110 26.8 
  100-199 cell/mm3 150 36.6 
  200-349 cell/mm3 133 32.4 
   >=350 cell/mm3 17 4.1 
WHO stage I 105 25.6 
  II 73 17.8 
  III 172 42 
  IV 60 14.6 
Baseline weight <70 kg 387 94.1 
  >=70 kg 23 5.9 
CPT Yes 401 97.8 
  No 9 2.2 
 
Prevalence and trends of  late ART initiation
The median (IQR) CD4 count at initiation of  ART was 
162.5 cell/μl (90.5-235.5). A total of  276 (67.3%, 95% CI 
62.70 %-71.7%) patients were categorized as having late 
ART initiation (Figure 1). Between the year 2009-2014, 
the proportion of  late ART initiation is decreased from 
77.78%  to 52.94%. 
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Figure 1: Proportion of patients with late ART therapy by calendar year 
The overall median CD4 count  over time increased 
from138 (72-196)cell/mm3 in 2009-2010 ,to 285(163-
323) cell/mm3 in 2013-2014 (figure 2). Among patients 
with late ART initation, the median (IQR) CD4 count at 
initiation of  ART was 117.5(66-164.5) cell/mm3.   
Factors associated with late ART initiation
In multivariable logistic regression analysis, age, marital 
status, level of  education, duration between HIV testing 
and enrollment to care, medication before ART initiation 
years of  ART initiation,  and baseline functional status 
were significantly associated with late ART initiation (Ta-
ble 2).
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Table2: Bivariable  and multivariable logistic regression analysis of factors associated with late ART initiation among adult HIV 
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Table2 (continued): Bivariable and multivariable logistic regression analysis of factors associated with late ART initiation among 
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Accordingly, the odds of  late ART initiation among adult 
HIV infected patients who were in the age group between 
35-44 years were 3.85 times higher as compared with 
age categories between 15-24 year at (AOR=3.85; 95% 
CI 1.68-8.82). Those adult HIV patients who were not 
married were 1.88 times more likely to initiate ART late 
(AOR=1.88; 95% CI 1.13-3.03) as compared to marrieds. 
This study also revealed that those adult HIV patients 
who had completed secondary and tertiary school were 
2.59 (AOR=2.59; 95% CI 1.36-4.94) and 3.28(AOR=3.28; 
95% CI1.25-8.64) times more likely to initiate ART late 
as compared with the non-educated. Those patients who 
had <1 year duration between HIV testing and enrollment 
to care were 2.19 times more likely to initiate ART lately 
as compared with those who had ≥ 1 year in duration 
(AOR=2. 19; 95% CI 1.30-3.69). Those adult HIV pa-
tients who took other medication before ART were 2.18 
times more likely to initiate ART late (AOR=2.18; 95% 
CI 1.07-4.44) compared with those who were not taking 
other medication. Moreover, the odds of   late ART initia-
tion among adult HIV patients who were ambulatory and 
bedridden were 4.68 times more likely to initiate ART late 
(AOR=4.68; 95%CI 1.49-14.68)  compared to those who 
were working functional status at baseline.  
 
  
Figure 2: Median CD4 cell count at initiation of antiretroviral  
therapy by calendar year (n=410) 
Discussion
In this study, the prevalence of  late ART initiation 
among adult HIV patients was found to be 67.3% (62.70 
%-71.70%). The current prevalence is higher as com-
pared to a previous study in Ethiopia which reported a 
prevalence of  31.2%15.  Late ART initiation in the pre-
vious study was defined as (CD4 count <150 cells/mL 
or WHO Stage IV which might have contributed for the 
lower magnitude.  Additionally, the earlier data collection 
period in the current study (from 2009 to 2014) might 
also contributed for the higher proportion of  late ART 
initiation when compared with 2012-2013 data collection 
time for the previous study.  This finding is in line with 
study in Nigeria 63.0%12, but higher than the findings in 
Lesotho 45.70%1 , Uganda 37.70%10, Cameroon 35.5%14, 
Mozambique 38.00%13,  Canada 48.0%2,  and Australia 
20.0%6. The higher magnitude of  lost to follow up or pre-
ART attrition after enrollment to HIV care and before 
initiation of  ART, late HIV diagnosis and  presentation 
to care in Ethiopia may attributed for this difference3,16. 
In the contrary, the prevalence of  late ART initiation in 
this study is  lower as compared to a study done in Latin 
America and Caribbean 76.0%11. This difference could 
be attributed to the difference in the time of  CD4 count 
measurement between these two studies. The Caribbean 
study defined late ART initiation as CD4 counts less than 
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200 cell/µl at any time prior to initiation of  ART, but in 
this study, we defined it as CD4 count less than 200 cell/
µl within one months before and after initiation of  ART. 
The time variation in the data collection period could also 
have contributed for this difference (from 1999-2010 for 
Caribbean study).  Since, early in the era of  HIV only 
limited number of  patients were eligible for ART.
In this study, median CD4 count at initiation of  ART over 
time (from 2009 to 2014) was 162.5 (90.5-235.5) Cell/µl. 
The median CD4 count over time increases from 138(72-
196) cell/mm3 in 2009-2010 to 285 (163-323) cell/mm3 in 
2013-2014. At the same time, the proportion of  patients 
who started ART late decreased over time from 77.78% 
to 52.94% within the study period. This finding is consis-
tent with other similar studies8,9,13. This indicates the great 
improvement on HIV prevention and treatment that 
has been made in Ethiopia for the last few years. Since 
2003, in which the first treatment guidelines developed, 
the guidelines were revised 4 times. Those patients’ eligi-
ble for initiation can obtain ART for free. Routine CD4 
cell count measure and regular clinical follow up support 
the HIV scale-up program and further contributed for 
the earlier initiation of  ART. Despite this intervention, in 
2014 more than half  (52.94%) of  patients initiate ART 
late and thus much more effort is still needed for future 
prevention and treatment strategy in accordance with 
UNAIDS 90-90-90 strategy by the year 202024
In this particular study, adult HIV patients who were in 
the age group between 35-44 years were 3.85 times higher 
to initiate treatment late as compared with those whose 
age was between 15-24 years (AOR=3.85; 95% CI 1.68-
8.82). A study among adult HIV patients in Cameroon 
also revealed that age younger than 45 years was associat-
ed with late ART initiation10,14. This age groups has more 
chance to present to HIV care late25.
This study also found that late ART initiation was sig-
nificantly associated with marital status. Unmarried adult 
HIV patients were 1.88 times more likely to initiate ART 
late (AOR=1.88; 95% CI 1.13-3.03) as compared to mar-
ried once. This finding is in line with Mozambique and 
Ugandan studies10,13. HIV care partner notification or dis-
closure could play a positive influence to initiate HIV early. 
Surprisingly, this study revealed that those adult HIV pa-
tients who have completed secondary and tertiary school 
were 2.59 and 3.28 times more likely to initiate ART late 
as compared with the un-educated, (AOR=2.59; 95% CI 
1.36-4.94) and (AOR=3.28; 95% CI1.25-8.64) respec-
tively. This finding is the contrary to the finding  from 
a Mozambique study13. This could be explained by the 
educational status difference which might have an impact 
on HIV testing and earlier presentation to care among 
un-educated patients in our hospital. The expectation of  
health professional among educated patients’ might cre-
ate psychological and emotional stress to attend health 
institution before developing advanced disease. Duration 
between HIV testing and enrollment to care is also the 
other factor. The odds of  late ART initiation among adult 
HIV patients who had less than one year’s duration be-
tween HIV testing and enrollment to care were 2.19 times 
higher as compared with those who had greater or equal 
to one year in duration (AOR=2. 19; 95% CI 1.30-3.69). 
This finding is contrary to the one from a study done in 
Nigeria and other four sub-Saharan African countries8,12. 
Patients presented to care having  advanced stages of  
disease need admission, and this enforces better health 
seeking behavior of  the patient7. Additionally, poor socio 
-economical status might affect patients’ strict follow up 
based on the recommendation, which in turn leads to late 
ART initiation.
Moreover, this study revealed that those adult HIV pa-
tients who took other medication before ART were 2.18 
times more likely to initiate ART late (AOR=2.18; 95% 
CI 1.07-4.44) as compared with those who were not tak-
ing other medication. This could be due to  the fact that 
many medications are given to the patient for manage-
ment of  opportunistic infection which might indicate the 
presence of  advanced disease and/or sever immuno-sup-
pression before initiation of  ART, which directly describe 
slate initiation.
Finally, those adult HIV patients who were ambulatory 
and bedridden were 4.68 times more likely to initiate ART 
late (AOR=4.68; 95%CI 1.49-14.68) as compared with 
those who had a working functional status at baseline. 
Another study from South West Ethiopia also came up 
with a similar finding26. This is due to the fact that  ambu-
latory and bedridden functional status is an indicator of  
low immune status and the presence  associated opportu-
nistic infection27.
Our study also had some limitations. First, many patients 
initiating ART with late stage of  HIV already had ad-
vanced infection at enrollment in HIV care, and likely of-
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ten at diagnosis making it challenging to directly identify 
correlates of  late ART initiation from factors related to 
late enrollment or diagnosis. Second, because of  the ret-
rospective nature of  the study some important variables 
like psychosocial and income related factors were missing 
in the patient’s record which could affect the results.
 
Conclusion
The prevalence of  late ART initiation was found to be 
high. The median CD4 count is increased over time. Ac-
cordingly, the proportion of  late ART initiation decreased 
over time inconsistently. However, significant proportion 
of  HIV patients started ART late. Patients who had fin-
ished secondary education and above, were aged between 
35-44, were unmarried, were taking medication before 
ART initiation, years of  ART initiation between 2009-
2012, duration between HIV testing and enrollment to 
care less than one year, ambulatory and bedridden func-
tional status were more likely to initiate ART late. This 
study highlights the need to strengthen the mechanisms 
of  early HIV testing as well as early enrolment/linkage to 
care and early ART initiation among adults in the com-
munity by intensively involving the health professionals 
and other stakeholders by advocating the current novel 
strategies (90-90 strategy). It is also better to enhance an 
intensive counseling and education for unmarried, am-
bulatory/bedridden patient and patients on other med-
ications. Further research to explore the socio-economi-
cal, institutional and contextual factors with appropriate 
study design is recommended.
 
List of  abbreviation
AIDS Acquired Immunodeficiency Syndrome
AOR Adjusted Odds Ratio
ART Anti-Retroviral Therapy
CI Confidence Interval
COR Crude Odds Ratio
CPT Co-trimoxazole Preventive Therapy
HAART Highly Active Anti-retroviral Therapy
HIV Human Immune Deficiency Virus
IQR Interquartile Range
I-TECH International Training and Education 
Center for Health
UNAIDS United Nations Programme on HIV/
AIDS
WHO World Health Organization
Declaration
Authors’ contributions
DZ conceived the idea and wrote the proposal, partic-
ipated in the data collection process, data analysis and 
drafted the paper. BA and BT approved the proposal with 
some revisions, participated in data analysis and reviewed 
the manuscript. All authors approved the final draft of  
the manuscript.
Acknowledgments
The authors would like to thank the data collectors for 
their collaboration during data collection. We would also 
like to thank University of  Gondar for providing ethical 
clearance.
Competing interests
The authors declare that they have no competing inter-
ests.
 
Availability of  data and materials
All relevant data are available within the manuscript
Authors’ information
1. DZ is a lecturer, Department of  Nursing, College of  
Medicine and Health Sciences at University of  Gondar, 
Ethiopia. DZ has Bachelor of  Science Degree in Nursing 
and Masters Degree in clinical tropical infectious disease 
and HIV medicine.
2. BT is a lecturer, Department of  nursing, College of  
Medicine and Health Sciences at University of  Gondar. 
BT has Bachelor of  Science Degree in Nursing, and Mas-
ters Degree in emergency and critical care nursing.
3. BA is an assistant Professor, Department of  Biostatis-
tics and Epidemiology, Institute of  Public Health, Col-
lege of  Medicine and Health Sciences at University of  
Gondar, Ethiopia and community service coordinator of  
college of  medicine and health science. BA has Bache-
lor of  Science Degree in Nursing, MSc in Adult Health 
Nursing, Masters of  Public Health in Biostatistics and 
Epidemiology Specialization.
Funding
The authors received no specific funding for this work.
 
References
1. Ford N, Kranzer K, Hilderbrand K, Jouquet G, Goe-
maere E, Vlahakis N, et al. Early initiation of  antiretrovi-
ral therapy and associated reduction in mortality, morbid-
African Health Sciences Vol 19 Issue 3, September, 20192332
ity and defaulting in a nurse-managed, community cohort 
in Lesotho. AIDS. 2010 Nov 13;24(17):2645-50. PubMed 
PMID: 20980868. Epub 2010/10/29. eng.
2. Cescon A, Patterson S, Davey C, Ding E, Raboud JM, 
Chan K, et al. Late initiation of  combination antiretroviral 
therapy in Canada: a call for a national public health strat-
egy to improve engagement in HIV care. J Int AIDS Soc. 
2015;18(1):20024. PubMed PMID: 26443752. Pubmed 
Central PMCID: PMC4595457. Epub 2015/10/08. eng.
3. Abaynew Y, Deribew A, Deribe K. Factors associated 
with late presentation to HIV/AIDS care in South Wol-
lo ZoneEthiopia: a case-control study. AIDS Res Ther. 
2011;8:8.  PubMed PubMed PMID: 21356115. Pubmed 
Central PMCID: PMC3058009. Epub 2011/03/02. eng.
4. Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne 
I, Suckow C, et al. Early antiretroviral therapy reduces 
AIDS progression/death in individuals with acute oppor-
tunistic infections: a multicenter randomized strategy tri-
al. PLoS One. 2009;4(5): PubMed e5575. PubMed PMID: 
19440326. Pubmed Central PMCID: PMC2680972. 
Epub 2009/05/15. eng.
5. Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni SG, Wu 
Y, et al. The problem of  late ART initiation in Sub-Sa-
haran Africa: a transient aspect of  scale-up or a long-
term phenomenon? J Health Care Poor Underserved. 2013 
Feb;24(1):359-83. PubMed PMID: 23377739. Pubmed 
Central PMCID: PMC3655523. Epub 2013/02/05. eng.
6. Wright ST, Law MG, Cooper DA, Keen P, McDonald 
A, Middleton M, et al. Temporal trends of  time to an-
tiretroviral treatment initiation, interruption and modifi-
cation: examination of  patients diagnosed with advanced 
HIV in Australia. Journal of  the International AIDS Society. 
2015;18:1-9.
7. Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, 
Tsai AC. Trends in CD4 count at presentation to care and 
treatment initiation in sub-Saharan Africa, 2002-2013: a 
meta-analysis. Clin Infect Dis. 2015 Apr 1;60(7):1120-7. 
PubMed PMID: 25516189. Pubmed Central PMCID: 
PMC4366582. Epub 2014/12/18. eng.
8. Lahuerta M, Wu Y, Hoffman S, Elul B, Kulkarni SG, Re-
mien RH, et al. Advanced HIV disease at entry into HIV 
care and initiation of  antiretroviral therapy during 2006-
2011: findings from four sub-saharan African countries. 
Clin Infect Dis. 2014 Feb;58(3):432-41. PubMed PMID: 
24198226. Pubmed Central PMCID: PMC3890338. 
Epub 2013/11/08. eng.
9. Kiertiburanakul S, Boettiger D, Lee MP, Omar SF, 
Tanuma J, Ng OT, et al. Trends of  CD4 cell count lev-
els at the initiation of  antiretroviral therapy over time 
and factors associated with late initiation of  antiretro-
viral therapy among Asian HIV-positive patients. J Int 
AIDS Soc. 2014;17:18804.  PubMed PubMed PMID: 
24598459. Pubmed Central PMCID: PMC3944639. 
Epub 2014/03/07. eng.
10. Sendagire I, Cobelens F, Kambugu A, Konde-Lule J, 
van der Loeff  MS. Frequency and predictors for late start 
of  antiretroviral therapy in primary care clinics, Kampala, 
Uganda. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):e33-
9. PubMed PMID: 22820807. Epub 2012/07/24. eng.
11. Crabtree-Ramirez B, Caro-Vega Y, Shepherd BE, We-
hbe F, Cesar C, Cortes C, et al. Cross-sectional analysis of  
late HAART initiation in Latin America and the Caribbe-
an: late testers and late presenters. PLoS One. 2011;6(5): 
PubMed e20272. PubMed PMID: 21637802. Pubmed 
Central PMCID: PMC3102699. Epub 2011/06/04. eng.
12. Agaba PA, Meloni ST, Sule HM, Agbaji OO, Ekeh 
PN, Job GC, et al. Patients who present late to HIV care 
and associated risk factors in Nigeria. HIV Med. 2014 
Aug;15(7):396-405. PubMed PMID: 24580742. Epub 
2014/03/04. eng.
13. Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, 
Okamura M, Alvim MF, Fernandes R, et al. Factors as-
sociated with late antiretroviral therapy initiation among 
adults in Mozambique. PLoS One. 2012;7(5):e37125. 
PubMed PMID: 22615917. Pubmed Central PMCID: 
PMC3352894. Epub 2012/05/23. eng.
14. Ndawinz JD, Chaix B, Koulla-Shiro S, Delaporte E, 
Okouda B, Abanda A, et al. Factors associated with late 
antiretroviral therapy initiation in Cameroon: a repre-
sentative multilevel analysis. J Antimicrob Chemother. 2013 
Jun;68(6):1388-99. PubMed PMID: 23391713. Epub 
2013/02/09. eng.
15. Nash D, Tymejczyk O, Gadisa T, Kulkarni SG, Hoff-
man S, Yigzaw M, et al. Factors associated with initiation 
of  antiretroviral therapy in the advanced stages of  HIV 
infection in six Ethiopian HIV clinics, 2012 to 2013. Jour-
nal of  the International AIDS Society. 2016;19(1):20637.
16. Melaku Z, Lamb MR, Wang C, Lulseged S, Gadisa 
T, Ahmed S, et al. Characteristics and outcomes of  adult 
Ethiopian patients enrolled in HIV care and treatment: 
a multi-clinic observational study. BMC Public Health. 
2015;15:462.  PubMed PubMed PMID: 25934178. 
Pubmed Central PMCID: PMC4455051. Epub 
2015/05/03. eng.
17. Ministry of  Health. National Comprehensive HIV 
Care and Treatment Training for Health care Providers. 
ethiopia2014.
African Health Sciences Vol 19 Issue 3, September, 2019 2333
18. Federal Ministry of  Health. National Comprehensive 
HIV Prevention, Care and Treatment Training for Health 
care Providers. Jaunary, 2018.
19. Poudel KC, Buchanan DR, Poudel-Tandukar K. De-
lays in antiretroviral therapy initiation among HIV-pos-
itive individuals: results of  the positive living with HIV 
study. Glob Health Action. 2016;9:31550.  PubMed PubMed 
PMID: 27369221. Epub 2016/07/03. eng.
20. Ndahimana J, Riedel DJ, Mwumvaneza M, Sebuho-
ro D, Uwimbabazi JC, Kubwimana M, et al. Drug resis-
tance mutations after the first 12 months on antiretroviral 
therapy and determinants of  virological failure in Rwan-
da. Trop Med Int Health. 2016 Jul;21(7):928-35. PubMed 
PMID: 27125473. Epub 2016/04/30. eng.
21. Wolbers M, Bucher HC, Furrer H, Rickenbach M, 
Cavassini M, Weber R, et al. Delayed diagnosis of  HIV 
infection and late initiation of  antiretroviral therapy in the 
Swiss HIV Cohort Study. HIV Med. 2008 Jul;9(6):397-
405. PubMed PMID: 18410354. Epub 2008/04/16. eng.
22. Birhanu AM, Bisetegn TA, Woldeyohannes SM. 
High prevalence of  substance use and associated factors 
among high school adolescents in Woreta Town, North-
west Ethiopia: multi-domain factor analysis. BMC Public 
Health. 2014;14(1):1186 PubMed .
23. Ministry of  health E. National Comprehensive HIV 
care and Treatment training for Health care provider 
june,2014.
24. UNAIDS. ambitious treatment targets: writing the fi-
nal chapter of  the AIDS epidemic: writing the final chap-
ter of  the AIDS epidemic, Geneva. 2014.
25. Fomundam H, Tesfay A, Mushipe S, Mosina M, 
Boshielo C, Nyambi H, et al. Prevalence and predictors 
of  late presentation for HIV care in South Africa. South 
African Medical Journal. 2017;107(12):1058-64.
26. Gesesew H, Tsehaineh B, Massa D, Tesfay A, Kahsay 
H, Mwanri L. The prevalence and associated factors for 
delayed presentation for HIV care among tuberculosis/
HIV co-infected patients in Southwest Ethiopia: a retro-
spective observational cohort. Infectious diseases of  poverty. 
2016;5(1):96.
27. Thejus T, Jeeja M, Jayakrishnan T. The functional sta-
tus of  patients with AIDS attending antiretroviral treat-
ment center. Indian J Palliat Care. 2009 Jan;15(1):57-60. 
PubMed PMID: 20606857. Pubmed Central PMCID: 
PMC2886209. Epub 2009/01/01. eng.
African Health Sciences Vol 19 Issue 3, September, 20192334
